Using targeted radiation to improve CAR T cell therapy for neuroblastoma in children
Targeted Radionuclide Therapy to Enhance the Efficacy of CAR T Cells Against Neuroblastoma
This study is looking at a new way to make CAR T cell therapy work better for kids with neuroblastoma by adding a special low-dose treatment that helps the CAR T cells target and destroy the tumors more effectively.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10985352 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of CAR T cell therapy, a type of immunotherapy, by combining it with low-dose targeted radionuclide therapy (TRT) specifically for treating neuroblastoma in children. The approach aims to sensitize tumors, making them more susceptible to destruction by CAR T cells. The research is being conducted by Dr. Quaovi Sodji at the University of Wisconsin-Madison, who is receiving mentorship from experts in immunology and radionuclide therapy. The project includes training in tumor immunology, radiochemistry, and laboratory management to ensure a comprehensive understanding of the treatment mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with neuroblastoma.
Not a fit: Patients with neuroblastoma who are not eligible for CAR T cell therapy or those with advanced-stage disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for children with neuroblastoma, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promising results in combining immunotherapy with targeted radiation, suggesting that this approach could be effective for treating neuroblastoma.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Sodji, Quaovi H — University of Wisconsin-Madison
- Study coordinator: Sodji, Quaovi H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.